Partnering plays a strategic role in executing our R&D strategy, evolving our portfolio and growth. Our goal in partnering is to discover, develop and deliver transformational medicines to patients by bringing innovative science, research and technology together with our capabilities and expertise.

Partnering to Speed: Transformational Medicines to Patients

Partnering to Speed: Transformational
Medicines to Patients

Combining passion, science and experience to deliver innovation together.

Why Partner With Us

With a long history of successful scientific and commercial collaborations that exhibit speed, collaboration, innovation, and strong partner relationships, research and development (R&D) is at the center of our strategy. With 41 compounds in development, a network of research facilities around the globe, and an annual R&D investment of $4.8 billion*,  we’ve been recognized as one of the premier R&D organizations in the industry.

*This non-GAAP amount excludes significant upfront and milestone payments for business development transactions and other specified R&D items. 

What We're Focused On

We are focused on building a differentiated portfolio of transformational medicines for patients with serious and life-threatening diseases. There are a number of areas of focus across disease areas, drug platforms and technologies that we are interested in bringing together with our expertise to help speed medicines to patients.

Existing Partnerships

In order to develop innovative medicines, we collaborate with top tier organizations and research institutes around the world.

Common Cold

Working to #HackCancer

Bristol Myers Squibb Joins Parker Institute and Cancer Research Institute to Accelerate I-O Research

Contact us about partnering

Start the partnership process. Please send NON-CONFIDENTIAL information about your opportunity to one of the individuals below based on your area of interest:

Hematology & Cell Therapy:
Neuroscience & CV:
Fibrosis & Immunology:
PDx and Biomarker:
Research and Enabling Transactions:
Digital Health Initiatives:
Corporate Development: